Whereas our ELISA assays could not differentiate between pro- and mature BDNF or NGF levels in plasma, further research will be required to elucidate potential shifts in the stoichiometry of these neurotrophin moieties and the mechanistic contributions of differential neurotrophin signaling to adverse events such as PTSD. This evidence concerns the gene BDNF and post-traumatic stress disorder.